SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-026401
Filing Date
2017-11-15
Accepted
2017-11-15 17:26:58
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 13099
  Complete submission text file 0000899243-17-026401.txt   15536
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171206076

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171206078

Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Capital GP IV LLC (Reporting) CIK: 0001502240 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171206077